MedTrace Logo

Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans

NCT02157779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2021-11-18

Study results available
· View outcomes & findings →

Summary

Excessive and poorly controlled anger is one of the most common problems experienced by war Veterans. The consequences can be severe, including increased risk for divorce, domestic violence, job loss and instability, and other serious impairments in family, social, and occupational functioning. Availability of effective treatments is critical to reducing the adverse effects of anger in Veterans. The investigators propose to conduct a controlled study to determine whether a cognitive behavior treatment that has been adapted for treating anger problems in Veterans of Iraq and Afghanistan results in improved outcomes compared to a supportive therapy. Results will be examined for improvement in anger, functioning, and quality of life at end of 12 weekly sessions, and at 3 and 6 months following treatment.

Conditions

  • Anger Problems

Interventions

BEHAVIORAL

Cognitive Behavioral Intervention

Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management

BEHAVIORAL

Supportive Intervention

Includes individual therapy sessions using supportive and problem-solving strategies.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Tracie M. Shea, PhD · Providence VA Medical Center, Providence, RI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02157779 on ClinicalTrials.gov